Observations on the Growth and Plaque Assay of BK Virus in Cultured Human and Monkey Cells
(Accepted 20 September I977) SUMMARY Although human embryo kidney (HEK), muscle (HEM) and lung (HEL) cells are capable of supporting the replication of BK virus (BKV) through passage levels 9, I2 and Iz respectively, only third, fourth and fifth passage level HEK ceils were found to be satisfactory for the plaque assay of the virus. BSC-I and VERO cells can also be used for the plaque assay of BKV. However, in HEK cells plaques can be visualized in zo days (compared to z8 days in BSC-I cells), and since in VERO cells the plaques are poorly defined and the titre about I log10 lower than in either HEK or BSC-I cells, HEK cells were the ones chosen for use.
The literature contains numerous descriptions of plaque assays for papovaviruses: polyoma virus on either mouse embryo or baby mouse kidney cells (Dulbecco & Freeman, I959; Winocour & Sachs, I959; Wildy et al. 196o ; Sheinin, I960; SV4o on either primary African green monkey kidney cells or on cells of the established monkey kidney lines, CV-I and BSC-I (Stinebaugh & Melnick, I962; Riggs & Lennette, I965; Takemoto, Todaro & Habel, I968) ; and more recently, a human papovavirus (RFV) on human embryo kidney cells (Dougherty & Di Stefano, I974) . In all cases, plaques can be visualized within 2 weeks of infecting the monolayers.
Plaque assays for the human papovavirus BK virus (BKV; Gardner et al. I97 I) have also been described, using either primary or secondary cultures of HEK cells (Major & Di Mayorca, 1973) or primary cultures of human embryonic cells (tissue of origin not specified; Van Der Noordaa, I976). This agent presents particular problems with respect to plaque assays. First, since it is a slowly developing virus, monolayers of permissive cells must be able to survive under nutrient agar fox periods of from 3 to 5 weeks in order for plaques to develop. Secondly, as reported earlier (Seehafer et al. I975) BKV remains strongly membrane associated in some cell types, even after extensive cytopathology has developed, and the failure of the infected cells to release progeny virions slows the development of plaques. In this paper we have summarized the results of our attempts to develop a reliable plaque assay for BKV on cultured human and monkey cells.
Cultures of HEK, HEM and HEL cells were established from cell suspensions prepared by trypsinization of the minced tissues from foetuses obtained from legal abortions. VERO and BSC-I cells were purchased from the American Type Culture Collection, Rockville, Md. In all cases, cells were grown in Dulbecco's modified Eagle's medium (DME) supplemented with 5 o/foetal calf serum (FCS). With the human cells, the medium was changed I day after setting up the primary cultures, and confluent monolayers were formed in 2 to 3 days, at which time cells were harvested by trypsinization and replated at 5o ~ confluency. Subsequent passages were made at two day intervals, employing a x : 2 split at each passage and changing the medium I day after subculturing. Handled in this way, HEK cells can be passaged 8 to Io times, and HEM and HEL cells at least I2 times. Virus pools (clarified cell lysates) were produced by growing plaque-purified BKV in HEK cells (input multiplicity < IO-3). 
Short communications
* In this and subsequent tables, the numbers indicate the passage level. "t" Expressed as HAU x io-8/cm 2 of monolayer. .:!: n.d. = not determined. § Input multiplicity = 640 HAU/cm ~. Ii Input multiplicity = 1ooo HAU/cm ~.
Initial attempts to develop a plaque assay were made with primary cultures of HEK cells, since it had been found that these cells, when infected at a multiplicity of one or more, release progeny virions as early as 5 days p.i., and are lysed completely by 14 to I7 days p.i. These attempts were unsuccessful, due to the failure of primary HEK cultures to survive under the agar overlay for a sufficiently long period of time. This prompted us to examine the replication of BKV in later cell passages (secondary, tertiary.., etc.) of HEK as well as of HEM and HEL cells. VERO and BSC-I cells were included in the study for purposes of comparison.
Confluent monolayers in 60 mm plastic Petri dishes were infected by incubation for 90 min at 37 °C with 0.2 ml volumes of a BKV suspension, after which 5 ml of DME -5 ~ FCS were added to each. Except where indicated, the input multiplicity was I28 haemagglutinating units (HAU)/cm 2 of monolayer (about Io p.f.u./cell). The medium was changed on all cultures at I day p.i. Every 7 days thereafter, one culture from each group was harvested and the medium was changed on all other cultures. This was continued until cytopathology was complete. The harvested cultures were incubated in the presence of 0"25 ~ NP-4o for 30 min at 37 °C to release virions from cellular membranes, and virus production was monitored by HA titrations performed as described earlier (Seehafer et al. I975 ).
The results, summarized in Table I , show that HEK, HEM and HEL cells are capable of supporting the replication of BKV through passage levels 9, 7 and 6 respectively, without any significant reduction in virus yield. In a separate experiment (data not shown), HEM No viable cells Intact, ceils viable for 3 days post-staining Intact, cells viable for 3 days post-staining Intact, cells viable for 3 days post-staining Intact, cells viable for 3 days post-staining Intact, cells viable for 3 days post-staining Intact, cells viable for 7 days post-staining Intact, cells viable for 7 days post-staining /zg meticortelone/ml. and HEL cells were shown to retain the ability to support the replication of this virus through I2 passages. The yield of virus from VERO cells, infected with I28 HAU/cm 2 of monolayer, was found to be in the same range as that from HEK, HEM and HEL cells infected at the same multiplicity, but to be somewhat higher at a higher input multiplicity. Even at a higher input multiplicity, the yield of virus from BSC-~ cells was found to be lower than those from all the other celltypes examined. Maximum virus yields from HEK and VERO cells were obtained in about 2 weeks, and from HEM, HEL and BSC-I cells in 3 to 4 weeks.
HEK, HEM and HEL cells at various passage levels, as well as VERO and BSC-I cells, were then tested in plaque assays for BKV. Confluent monolayers were infected and overlaid with Io ml of DME-5 ~o FCS containing I2"5 mM-HEPES (pH 7"4) and o'9 ~N oble agar. After incubation at 37 °C for various periods of time, monolayers were stained to visualize any plaques that had been produced, by adding 5 ml DME-5 ~ FCS containing o-o~ ~ neutral red to each dish and incubating for 6 h. The results are summarized in Table 2 .
Plaques were not produced in primary and secondary cultures of HEK cells, due to the failure of the cells to survive under the agar overlay. However, plaques were formed reproducibly in HEK cells at the third, fourth and fifth passage levels. With cells at the sixth passage level, plaque formation was variable. The optimal time for staining HEK cell monolayers was found to be 19 to 2o days p.i. Reliable plaque counts may be made from 24 to 72 h thereafter, after which time the monolayers deteriorate.
Early passages of HEM and HEL cells, like primary and secondary HEK cells, fail to survive under agar overlay. Later passages of HEM and HEL cells remain viable under agar overlay for at least 37 and 26 days respectively, but in no case was plaque formation observed. Modifying the experimental conditions (e.g. varying the serum concentration in the overlay, adding the glucocorticoid, meticortelone [Schering Corp.] , to the overlay, periodic feeding of the monolayers by adding additional agar overlay or incubating for Short communications several hours with DME-5 % FCS) did not alter the situation. BKV plaques were never seen in monolayers of HEM and HEL cells, despite the fact that the latter are permissive for the virus (see Table I ), and retain their viability under agar for 4 to 5 weeks. This observation may be explained by the fact that BKV remains highly membrane-associated in these cells.
BKV was also found to produce plaques in monolayers of the established monkey kidney cell lines, BSC-I and VERO. With BSC-I cells, reproducible plaque counts are obtained in monolayers stained at any time from 27 to 35 days p.i., while with VERO ceils, monolayers should be stained at 14 days p.i. and plaques counted between I7 and 2o days p.i. In the case of VERO cells it was found necessary to harvest and subculture the cells at least 32 or times at 48 h intervals (using a I:2 split each time) before using them for plaque assays. Plaques were not produced in monolayers established from stock cultures that had been held at confluency for several days. In addition, reproducible plaque assays were obtained in VERO cells only if meticortelone 0o #g/ml) was added to the agar overlay.
To compare the efficiency of plaque formation by BKV in human and monkey cells, a single virus sample (containing 3"2 x I@ HAU/ml) was titrated on HEK (third, fourth and fifth passages), BSC-I and VERO cells. The data showed that the titres obtained with HEK and BSC-I cells do not differ significantly, and exceed by a factor of about IO the titre obtained with VERO cells. This finding has been verified repeatedly. P.f.u./HAU ratios, based on plaque assays in monolayers of HEK or BSC-I cells, were in the range 2 to 5 x Io 3. In separate experiments, p.f.u./HAU ratios as high as, but never exceeding, lO 4 have been obtained. The low titres obtained with VERO cell monolayers are puzzling in that the yield of virus obtained from infected VERO cell monolayers is comparable to that obtained from infected HEK cell monolayers and exceeds that obtained from infected BSC-I cell monolayers. One possibility (that has not been examined directly) is that BKV attaches with lower efficiency to VERO than to either HEK or BSC-I cells. The observation made in this laboratory that only about 5 % of ceils in a VERO cell monolayer stain positively for BKV-T antigen 48 h after infection at a m.o.i, of Ioo tends to support this suggestion.
The morphology of plaques produced in HEK and BSCq cell monolayers is quite similar. In both cell types, plaques are well defined and easy to count. In VERO cells, plaques are less well defined and more difficult to count. Plaque sizes were found to vary considerably in monolayers of all three cells even with virus samples that had been twice plaque purified.
In conclusion, third, fourth and fifth passage HEK cells as well as BSC-I cells have been found to be satisfactory for the plaque assay of BKV, although HEK cells are the cell of choice in that plaques can be counted within 2o days (as compared to 28 days in the case of BSC-I cells). BKV also produces plaques in VERO cells in 2o days, but the fact that the plaques are poorly defined (and the titre about I log10 lower than that obtained in either HEK or BSC-I cells) makes these cells a poor third choice. 
